de Vries CJ - Search Results

1

Nur77 modulates hepatic lipid metabolism through suppression of SREBP1c activity.

Pols TW, Ottenhoff R, Vos M, Levels JH, Quax PH, Meijers JC, Pannekoek H, Groen AK, de Vries CJ. Pols TW, et al. Among authors: de vries cj. Biochem Biophys Res Commun. 2008 Feb 22;366(4):910-6. doi: 10.1016/j.bbrc.2007.12.039. Epub 2007 Dec 18. Biochem Biophys Res Commun. 2008. PMID: 18086558

2

Kinetic characterization of tissue-type plasminogen activator (t-PA) and t-PA deletion mutants.

de Vries C, Veerman H, Nesheim ME, Pannekoek H. de Vries C, et al. Thromb Haemost. 1991 Mar 4;65(3):280-5. Thromb Haemost. 1991. PMID: 1904654

3

Tissue-type plasminogen activator and its substrate Glu-plasminogen share common binding sites in limited plasmin-digested fibrin.

de Vries C, Veerman H, Koornneef E, Pannekoek H. de Vries C, et al. J Biol Chem. 1990 Aug 15;265(23):13547-52. J Biol Chem. 1990. PMID: 2143185 Free article.

4

Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.

Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H. Wagner OF, et al. J Clin Invest. 1989 Aug;84(2):647-55. doi: 10.1172/JCI114211. J Clin Invest. 1989. PMID: 2503541 Free PMC article.

5

Identification of the domains of tissue-type plasminogen activator involved in the augmented binding to fibrin after limited digestion with plasmin.

de Vries C, Veerman H, Pannekoek H. de Vries C, et al. J Biol Chem. 1989 Jul 25;264(21):12604-10. J Biol Chem. 1989. PMID: 2526127 Free article.

6

Artificial exon shuffling between tissue-type plasminogen activator (t-PA) and urokinase (u-PA): a comparative study on the fibrinolytic properties of t-PA/u-PA hybrid proteins.

de Vries C, Veerman H, Blasi F, Pannekoek H. de Vries C, et al. Biochemistry. 1988 Apr 5;27(7):2565-72. doi: 10.1021/bi00407a044. Biochemistry. 1988. PMID: 3132969

7

The specific roles of finger and kringle 2 domains of tissue-type plasminogen activator during in vitro fibrinolysis.

Horrevoets AJ, Smilde A, de Vries C, Pannekoek H. Horrevoets AJ, et al. J Biol Chem. 1994 Apr 29;269(17):12639-44. J Biol Chem. 1994. PMID: 8175674 Free article.

8

Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes.

Horrevoets AJ, Fontijn RD, van Zonneveld AJ, de Vries CJ, ten Cate JW, Pannekoek H. Horrevoets AJ, et al. Among authors: de vries cj. Blood. 1999 May 15;93(10):3418-31. Blood. 1999. PMID: 10233894 Free article.

9

Human activin-A is expressed in the atherosclerotic lesion and promotes the contractile phenotype of smooth muscle cells.

Engelse MA, Neele JM, van Achterberg TA, van Aken BE, van Schaik RH, Pannekoek H, de Vries CJ. Engelse MA, et al. Among authors: de vries cj. Circ Res. 1999 Nov 12;85(10):931-9. doi: 10.1161/01.res.85.10.931. Circ Res. 1999. PMID: 10559140 Free article.

10

Differential display identification of 40 genes with altered expression in activated human smooth muscle cells. Local expression in atherosclerotic lesions of smags, smooth muscle activation-specific genes.

de Vries CJ, van Achterberg TA, Horrevoets AJ, ten Cate JW, Pannekoek H. de Vries CJ, et al. J Biol Chem. 2000 Aug 4;275(31):23939-47. doi: 10.1074/jbc.M910099199. J Biol Chem. 2000. PMID: 10823842 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters